- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06426693
Craving Network Neurofeedback
Connectome-based Neurofeedback of the Craving Network to Reduce Food Cue Reactivity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim 1 of this study is to test whether neurofeedback from the craving network is associated with reduced craving network strength.
Aim 2 of this study is to test whether neurofeedback from the craving network is associated with reduced food craving and changes in eating behavior.
Aim 3 of this study is to test whether neurofeedback from the craving network is associated with changes in resting state functional connectivity.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kathleen A Garrison, PhD
- Phone Number: 2037376232
- Email: kathleen.garrison@yale.edu
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06519
- Recruiting
- Yale MRRC Anlyan Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ages 18 to 60 years
- Body mass index >25 kg/m2
- >2.37 Food Craving Inventory score
Exclusion Criteria:
- Current or past 6 months use of anti-obesity medications
- Weight-reduced state defined as >10% weight reduction in the past 6 months.
- Nicotine use
- Current diagnosis of neurological or psychiatric disorder
- Obesity-related diseases such as type-2 diabetes
- Contraindications to MRI
- Baseline scanning with motion >0.15mm frame to frame displacement.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neurofeedback
Three imaging (fMRI) sessions of experimental feedback.
|
Participants provided with feedback of target brain activation patterns (e.g., thermometer) and will be instructed to try to change the feedback (e.g., decrease the thermometer).
|
|
Sham Comparator: Control neurofeedback
Three imaging (fMRI) sessions of sham feedback.
|
Participants provided with control (sham, yoked to another participant) feedback (e.g., thermometer) and will be instructed to try to change the feedback (e.g., decrease the thermometer).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in craving network strength during transfer runs
Time Frame: Week 1 and 3
|
Craving network strength will be measured during transfer (i.e., no feedback) runs and compared across scan sessions.
|
Week 1 and 3
|
|
Change in Food Craving Inventory Mean Score
Time Frame: Week 1, Week 7
|
Food Craving Inventory has 28 items rated 1-5 and overall mean is calculated, range 1-5 with higher score indicating higher craving.
FCI will be compared between baseline and 1 month follow-up.
|
Week 1, Week 7
|
|
Change in Automated Self-Administered 24-hour (ASA24®) Dietary Assessment Tool Healthy Eating Index (HEI).
Time Frame: Week 1, Week 7
|
ASA-24 HEI is scored 0-100 with 100 indicating healthier diet and composite scores examined to interpret the overall score.
HEI will be compared between baseline and 1 month follow-up.
|
Week 1, Week 7
|
|
Change in craving network strength during resting state runs
Time Frame: Week 1 and 3
|
Craving network strength will be measured during resting state runs and compared across scan sessions.
|
Week 1 and 3
|
|
Change in Food Rating Task healthiness, tastiness, and choice scores
Time Frame: Week 1, Week 7
|
Food Rating Task outcomes include healthiness, tastiness, and choice.
Healthiness and tastiness mean score is taken, range 1-5, with 5 indicating higher healthiness or tastiness.
Choice is counted from 0-48 items choosing the food item over the neutral reference food item, with higher values indicating more frequent choice.
Food Ratings will be compared between baseline and 1 month follow-up.
|
Week 1, Week 7
|
|
Change in Food Snack Task caloric intake
Time Frame: Week 1 and 3
|
Food Snack Task will be used to measure caloric intake (out of a maximum value to calories offered) and compared across scan sessions.
|
Week 1 and 3
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathleen A Garrison, PhD, Yale University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000037084
- 1R01DK136623-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight or Obesity
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Recruiting
-
Universidad Católica San Antonio de MurciaEnrolling by invitationObesity | Overweight or ObesitySpain
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Hebei Medical University Third HospitalWestlake UniversityActive, not recruiting
-
Universidad Pablo de OlavideUniversity of SevilleCompletedObesity | Overweight and Obesity | Overweight or ObesitySpain
-
BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd...Recruiting
Clinical Trials on Experimental feedback
-
Yale UniversityNational Institute of Mental Health (NIMH); VA Connecticut Healthcare SystemTerminatedPost-Traumatic Stress DisorderUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Terminated
-
Khon Kaen UniversityCompletedSpinal Cord InjuriesThailand
-
McGill UniversityRecruitingSurgical EducationCanada
-
Hunan Provincial People's HospitalNot yet recruiting
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
University of MichiganCompletedDepression | Anxiety | Sleep Disturbance | AddictionUnited States
-
University Hospital, CaenUnknown
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance